Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.

Li ZW, Sun B, Gong T, Guo S, Zhang J, Wang J, Sugawara A, Jiang M, Yan J, Gurary A, Zheng X, Gao B, Xiao SY, Chen W, Ma C, Farrar C, Zhu C, Chan OTM, Xin C, Winnicki A, Winnicki J, Tang M, Park R, Winnicki M, Diener K, Wang Z, Liu Q, Chu CH, Arter ZL, Yue P, Alpert L, Hui GS, Fei P, Turkson J, Yang W, Wu G, Tao A, Ramos JW, Moisyadi S, Holcombe RF, Jia W, Birnbaumer L, Zhou X, Chu WM.

Gastroenterology. 2019 Jun;156(8):2297-2312. doi: 10.1053/j.gastro.2019.02.040. Epub 2019 Mar 2.

PMID:
30836096
2.

T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.

Pusic KM, Hashimoto CN, Lehrer A, Aniya C, Clements DE, Hui GS.

PLoS One. 2011;6(9):e24782. doi: 10.1371/journal.pone.0024782. Epub 2011 Sep 13.

3.

Training the next generation of minority health scientists: a STEP-UP in the right direction.

Hui GS, Pusic KM.

Hawaii Med J. 2011 Jul;70(7):152-3. No abstract available.

4.
7.

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.

Tine JA, Lanar DE, Smith DM, Wellde BT, Schultheiss P, Ware LA, Kauffman EB, Wirtz RA, De Taisne C, Hui GS, Chang SP, Church P, Hollingdale MR, Kaslow DC, Hoffman S, Guito KP, Ballou WR, Sadoff JC, Paoletti E.

Infect Immun. 1996 Sep;64(9):3833-44.

8.
9.
10.

Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea.

al-Yaman F, Genton B, Kramer KJ, Taraika J, Chang SP, Hui GS, Alpers MP.

Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):555-9.

PMID:
8560539
11.

Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.

Hui GS, Gosnell WL, Case SE, Hashiro C, Nikaido C, Hashimoto A, Kaslow DC.

J Immunol. 1994 Sep 15;153(6):2544-53.

PMID:
8077664
12.

Induction of antibodies to the Plasmodium falciparum merozoite surface protein-1 (MSP1) by cross-priming with heterologous MSP1s.

Hui GS, Hashimoto AC, Nikaido CM, Choi J, Chang SP.

J Immunol. 1994 Aug 1;153(3):1195-201.

PMID:
8027549
13.

Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.

Chang SP, Nikaido CM, Hashimoto AC, Hashiro CQ, Yokota BT, Hui GS.

J Immunol. 1994 Apr 1;152(7):3483-90.

PMID:
8144929
14.
15.

Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.

Hui GS, Hashiro C, Nikaido C, Case SE, Hashimoto A, Gibson H, Barr PJ, Chang SP.

Infect Immun. 1993 Aug;61(8):3403-11.

16.

An experimental vaccine cocktail for Plasmodium falciparum malaria.

Bathurst IC, Gibson HL, Kansopon J, Hahm BK, Green KM, Chang SP, Hui GS, Siddiqui WA, Inselburg J, Millet P, et al.

Vaccine. 1993;11(4):449-56.

PMID:
8470430
17.

Plasmodium falciparum: induction of biologically active antibodies to gp195 is dependent on the choice of adjuvants.

Hui GS, Chang SP.

Exp Parasitol. 1992 Aug;75(1):155-7. No abstract available.

PMID:
1639161
18.
20.

Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195.

Hui GS, Chang SP, Gibson H, Hashimoto A, Hashiro C, Barr PJ, Kotani S.

J Immunol. 1991 Dec 1;147(11):3935-41.

PMID:
1940375
21.
22.

Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Chang SP, Hui GS, Kato A, Siddiqui WA.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6343-7.

23.
24.

Ultrastructural localization of protective and nonprotective Plasmodium falciparum proteins using serum samples from vaccinated Aotus monkeys.

Atkinson CT, Aikawa M, Fujino T, Tam LQ, Hui GS, Siddiqui WA.

J Parasitol. 1987 Dec;73(6):1235-40.

PMID:
3325622
25.

Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro.

Hui GS, Siddiqui WA.

Exp Parasitol. 1987 Dec;64(3):519-22. No abstract available.

PMID:
3315738
26.

Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Siddiqui WA, Tam LQ, Kramer KJ, Hui GS, Case SE, Yamaga KM, Chang SP, Chan EB, Kan SC.

Proc Natl Acad Sci U S A. 1987 May;84(9):3014-8.

27.

Physostigmine reversal of general anesthesia for intraoperative neurological testing: associated EEG changes.

Artru AA, Hui GS.

Anesth Analg. 1986 Oct;65(10):1059-62. No abstract available.

PMID:
3752553
28.

Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.

Siddiqui WA, Tam LQ, Kan SC, Kramer KJ, Case SE, Palmer KL, Yamaga KM, Hui GS.

Infect Immun. 1986 Apr;52(1):314-8.

29.

Use of human plasma for continuous in vitro cultivation of Plasmodium falciparum.

Hui GS, Palmer KL, Siddiqui WA.

Trans R Soc Trop Med Hyg. 1984;78(5):625-6.

PMID:
6390805
30.

A large-scale in vitro production system for Plasmodium falciparum.

Palmer KL, Hui GS, Siddiqui WA, Palmer EL.

J Parasitol. 1982 Dec;68(6):1180-3. No abstract available.

PMID:
6757400
31.

Cochlear nucleus unit responses to pure tones in the unanesthetized rabbit.

Hui GS, Disterhoft JF.

Exp Neurol. 1980 Sep;69(3):576-88. No abstract available.

PMID:
7409065

Supplemental Content

Support Center